Clinical Trial: Extended-release of Octreotide (LF-PB) for the Treatment of Seroma

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Multicentre, Double Blind, Randomized Placebo Controlled Trial to Assess the Effect of LF-PB on Seroma Formation in Women With Breast Cancer Undergoing Axillary Lymph No

Brief Summary:

This is a multicentre, double blind, randomized placebo controlled trial to assess the effect of LF-PB on seroma formation in women with breast cancer undergoing Axillary Lymph Node Dissection (ALND).

Recruited patients will be randomly assigned to receive LF-PB 30 mg or placebo.